topical diclofenac 3% gel for actinic keratosis may induce terminal hair in male androgenetic alopecia: a report of three cases

نویسندگان

helena collgros department of dermatology, hospital universitari del sagrat cor, barcelona, spain; department of dermatology, hospital universitari del sagrat cor, barcelona, spain. tel: +34-933214998, fax: +34-934191923

joaquin sola ortigosa department of dermatology, hospital universitari del sagrat cor, barcelona, spain

maribel iglesias-sancho department of dermatology, hospital universitari del sagrat cor, barcelona, spain

چکیده

introduction recently topical 3% diclofenac is commonly used to treat actinic keratosis (ak). it is proposed that it may also have a potential effect on hair growth. case presentation three male patients were visited in the dermatology department and received treatment with topical 3% diclofenac gel because of scalp ak. all patients also had concomitant androgenetic alopecia (aga). during the follow-up visits, patients presented terminal hair growth on non-prior haired areas of the scalp. to the authors’ best knowledge, these are the first reported cases of hair growth due to topical diclofenac treatment. conclusions aga is a heritable, androgen-dependent process. various hypotheses proposed to explain its causes. authors hypothesized that the inhibition of the cox-2 shown by diclofenac might act over the perifollicular micro-inflammation and the prostaglandins misbalance observed in the aga, leading to hair growth. this finding may open further research lines to develop new treatments for aga.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Assessing clinically meaningful end points for the management of actinic keratosis with diclofenac 3% gel.

Actinic keratosis (AK) is an early stage of evolving skin cancer and may be classified as a squamous cell carci-noma (SCC) in situ, which originates from keratinocytes and appears on areas of skin exposed to sunlight, such as the face and arms. It is a common condition in the general population, with prevalence increasing with age and cumulative sun exposure. The American Academy of Dermatology...

متن کامل

Topical 3% diclofenac in 2.5% hyaluronan gel for the treatment of actinic keratoses.

Actinic Keratoses (AKs) are epidermal skin lesions that have the potential to develop into squamous cell carcinoma. Many of the treatment options available can cause discomfort, pain or skin irritation. Topical 3% diclofenac in 2.5% hyaluronan gel (Solaraze, Bioglan Pharma) is a relatively new treatment that has been shown to be effective and well tolerated for the treatment of AKs.

متن کامل

Topical Melatonin for Treatment of Androgenetic Alopecia

BACKGROUND In the search for alternative agents to oral finasteride and topical minoxidil for the treatment of androgenetic alopecia (AGA), melatonin, a potent antioxidant and growth modulator, was identified as a promising candidate based on in vitro and in vivo studies. MATERIALS AND METHODS One pharmacodynamic study on topical application of melatonin and four clinical pre-post studies wer...

متن کامل

Male androgenetic alopecia.

IMPORTANCE OF THE FIELD Androgenetic alopecia affects up to 80% of males by the age of 80. The synonym 'male-pattern hair loss' highlights the fact that hair loss occurs in a defined and reproducible pattern. Hair loss results in reduced self esteem, loss of confidence and anxiety in affected men. An effective treatment for hair baldness would be desirable. AREAS COVERED IN THIS REVIEW In and...

متن کامل

A New Topical Formulation of Minoxidil and Finasteride Improves Hair Growth in Men with Androgenetic Alopecia

Objectives: To compare the safety and efficacy of MorrF (combination of Minoxidil [5%]+Finasteride [0.1%] lipid solution) with Minoxidil (5%) solution in adult male patients suffering from Androgenetic Alopecia (AGA). Background: AGA is one of the three most common forms of non-scarring alopecia with approximately 95% of hair loss cases in men and women. Fifty percent of men by age 50 years exh...

متن کامل

New Topical Treatment Options for Actinic Keratosis: A Systematic Review.

This systematic review compared the relative efficacy of 5-fluorouracil 0.5% in salicylic acid 10% (5-FU/SA), ingenol mebutate (IMB) and imiquimod 2.5%/3.75% (IMI) for actinic keratosis on the face, forehead or scalp. Only 11 publications, relating to 7 randomised controlled trials, met inclusion criteria and it was only possible to compare the effect of all 3 treatments on complete clinical cl...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
journal of skin and stem cell

جلد ۲، شماره ۴، صفحات ۰-۰

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023